SARS-CoV-2 infection in a fully vaccinated case with newly diagnosed breast cancer: a case report
preprint
OA: closed
CC-BY-4.0
Abstract
BACKGROUND: the novel Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) was identified in 2019 inWuhan, China, and has not been previously identified in humans. SARS-CoV-2 disease resulted in a global pandemic, impacted on public health service and in major changes in the lifestyle and quality of life of population. CASE: we describe a 62-year-old woman with new diagnosis of breast cancer, infected with the SARS-CoV-2, within 14 days of the second dose of the BNT162b2 mRNA COVID-19 vaccine. CONCLUSION: in cancer population, timely vaccinations and maintenance of the maximum alert threshold, are necessary to prevent infection spreading.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-08-17T06:25:09.426038+00:00
License: CC-BY-4.0